Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

328
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
328
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

128
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
128
Psychoneuroimmunology: Diabetes and Cancer01:19

Psychoneuroimmunology: Diabetes and Cancer

19
Chronic stress has been linked to both the onset and progression of serious health conditions, including Type 2 diabetes and cancer. Type 2 diabetes, a widespread chronic illness, is closely associated with obesity and insulin resistance, both of which often worsen under stress. Studies indicate that men experiencing high levels of chronic stress face a 45% higher risk of developing diabetes compared to those with minimal stress. Stress triggers physiological responses that elevate blood...
19

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Exploring the fungistatic mechanism of glycoside hydrolase 17 family endo-β-1,3-glucanase from Vitis vinifera for effectively inhibiting phytopathogens.

International journal of biological macromolecules·2026
Same author

Association between high maternal haemoglobin levels in the first trimester and gestational diabetes mellitus: a prospective birth cohort study.

Journal of global health·2026
Same author

Time Resolved DNA Barcodes for Information Encoding and Dynamic Encryption.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026
Same author

Prediction of PD-L1 expression in nonsmall cell lung cancer using artificial intelligence models based on radiomics: a systematic review and meta-analysis.

European respiratory review : an official journal of the European Respiratory Society·2026
Same author

IgG4-related Autoimmune Hepatitis Mimicking Hepatic Malignancy Shown on 18 F-FDG PET/CT.

Clinical nuclear medicine·2026
Same author

Effects of microwave treatment on the physicochemical properties, structure, and in vitro digestibility of sweet potato starch-lipid complexes with different fatty acid chain lengths.

Journal of the science of food and agriculture·2026

Related Experiment Video

Updated: May 13, 2025

Fixation and Operational Method for Abdominal Massage in T2DM Mice
06:00

Fixation and Operational Method for Abdominal Massage in T2DM Mice

Published on: March 7, 2025

118

Diabetes affects AD through plasma Aβ40: A Mendelian randomization study.

Qiumin Yang1, Delong Huang1, Zhaojing Zhang1

  • 1Department of Rehabilitation, The Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan, China.

Neuroscience
|April 15, 2025
PubMed
Summary

This study found that diabetes increases Alzheimer's disease (AD) risk. Furthermore, it revealed a causal link between diabetes and plasma amyloid-beta 40 (Aβ40), a key AD biomarker.

Keywords:
Alzheimer’s diseaseAmyloid βDiabetesMendelian randomizationTau

More Related Videos

Quantitative 3D In Silico Modeling q3DISM of Cerebral Amyloid-beta Phagocytosis in Rodent Models of Alzheimer's Disease
09:33

Quantitative 3D In Silico Modeling q3DISM of Cerebral Amyloid-beta Phagocytosis in Rodent Models of Alzheimer's Disease

Published on: December 26, 2016

7.9K
A Method for Mouse Pancreatic Islet Isolation and Intracellular cAMP Determination
12:33

A Method for Mouse Pancreatic Islet Isolation and Intracellular cAMP Determination

Published on: June 25, 2014

65.1K

Related Experiment Videos

Last Updated: May 13, 2025

Fixation and Operational Method for Abdominal Massage in T2DM Mice
06:00

Fixation and Operational Method for Abdominal Massage in T2DM Mice

Published on: March 7, 2025

118
Quantitative 3D In Silico Modeling q3DISM of Cerebral Amyloid-beta Phagocytosis in Rodent Models of Alzheimer's Disease
09:33

Quantitative 3D In Silico Modeling q3DISM of Cerebral Amyloid-beta Phagocytosis in Rodent Models of Alzheimer's Disease

Published on: December 26, 2016

7.9K
A Method for Mouse Pancreatic Islet Isolation and Intracellular cAMP Determination
12:33

A Method for Mouse Pancreatic Islet Isolation and Intracellular cAMP Determination

Published on: June 25, 2014

65.1K

Area of Science:

  • Neurodegenerative diseases
  • Metabolic disorders
  • Genetics and epidemiology

Background:

  • Alzheimer's disease (AD) is characterized by amyloid and tau pathology.
  • A potential causal link exists between diabetes mellitus and AD, but specific diabetic traits and AD biomarkers require further investigation.
  • Existing literature lacks comprehensive analysis of the causal relationship between diabetic traits and AD biomarkers.

Purpose of the Study:

  • To systematically review and analyze the association between diabetes and AD.
  • To perform a two-sample Mendelian randomization (MR) analysis to investigate causal relationships between diabetic traits and AD biomarkers.
  • To explore potential causal links between various diabetic traits and specific AD plasma markers.

Main Methods:

  • Systematic literature review and meta-analysis using forest plots.
  • Two-sample Mendelian randomization (MR) analysis utilizing genome-wide association study (GWAS) summary statistics.
  • Exploration of causal relationships between individual diabetic traits (e.g., HbA1c) and AD biomarkers (e.g., plasma Aβ40, APLP2).

Main Results:

  • Meta-analysis confirmed that diabetes is associated with an increased risk of AD.
  • MR analysis demonstrated a significant causal relationship between diabetes and plasma amyloid-beta 40 (Aβ40).
  • MR analysis also identified a causal link between elevated HbA1c levels and plasma APLP2, suggesting broader implications for diabetic traits.

Conclusions:

  • Diabetes is a significant risk factor for Alzheimer's disease.
  • Specific diabetic traits, such as diabetes itself and elevated HbA1c, causally influence key AD biomarkers like plasma Aβ40 and APLP2.
  • Further research into the interplay between metabolic health and AD pathogenesis is warranted.